| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/05/2005 | CN1559509A Oral liquid for treating gastrodynia aerogastria, gastroxynsis |
| 01/05/2005 | CN1559504A Stomach and intestine root securing mistura having sea buckthorn oil |
| 01/05/2005 | CN1559500A Codonopsis effective component and preparaation method of its medicinal preparation of codenopsis rich paste |
| 01/05/2005 | CN1559495A Deer's fetus granular Chinese madicinal preparation and its production technology |
| 01/05/2005 | CN1559493A Medicine for treating hapatitis |
| 01/05/2005 | CN1559489A Black bean concentrated pill and its preparation method |
| 01/05/2005 | CN1559482A Preparation method of achillea effective part medicinal preparation |
| 01/05/2005 | CN1559476A Medicinal health protection product |
| 01/05/2005 | CN1559473A Cinnamon twig decoction drop pill and its preparation method |
| 01/05/2005 | CN1559471A Chinese medicine/preparation |
| 01/05/2005 | CN1559464A Medicine specially for treating gastrosis |
| 01/05/2005 | CN1559463A Medicine for treating viral hepatitis B |
| 01/05/2005 | CN1559451A Medicine compound having synergistic action |
| 01/05/2005 | CN1559446A Antimicrobial (tincture)medicine with functons of analgesia, hemostasis and relieving-itching |
| 01/05/2005 | CN1559445A Antimicrobial (aqua)medicine with functions of analgesia, hemostasis and reliveing-itching |
| 01/05/2005 | CN1559444A Oral liquid contg. extration of sturgeon and sturgeon active protein capsule, prepn. method therefor |
| 01/05/2005 | CN1559443A Sturgeon chondroition capsule and instant granula prepn. method therefor |
| 01/05/2005 | CN1559442A Soft capsule of dried oviduct fat of forest frog |
| 01/05/2005 | CN1559441A Method for preparing immune milk anti-pathogenic microoganism in digestive tract |
| 01/05/2005 | CN1559432A Medicine for treating infantile enterorrhea |
| 01/05/2005 | CN1559425A Method for preparing Baicalin prepn. for external use |
| 01/05/2005 | CN1559422A Oral medicine for eliminating pyloric spirillar bacilli |
| 01/05/2005 | CN1559415A Application of ligo-xylose in preparing medicine for treating enteric function disturbance |
| 01/05/2005 | CN1559414A Application oligo-xylose in preparing medicine for treating chronic hepatitis accompanying enteric functon disturbance |
| 01/05/2005 | CN1559406A Series medicine prepn. contg. tinidazole used as compound for anti-trichomoniasis and anti-anaerobic former |
| 01/05/2005 | CN1559401A Therapeutic use and compositions involving isoflavones |
| 01/05/2005 | CN1559400A Method for preparing scutellarein liquid |
| 01/05/2005 | CN1559398A Application of chalcone for preparing medicnes for treating hepatitis and hepatoma |
| 01/05/2005 | CN1559387A Intravenous injection liquid of coenzyme Q10, and its prepn. method |
| 01/05/2005 | CN1559386A Method for preparing emodin liquid |
| 01/05/2005 | CN1559269A Yeast protein composition for promoting digestion and assimilation by ruminants, and its prepn. method |
| 01/05/2005 | CN1183136C Indoloquinazolinones |
| 01/05/2005 | CN1183132C Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 01/05/2005 | CN1183127C Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 01/05/2005 | CN1183122C Dipeptide nitrile cathepsin K inhibitors |
| 01/05/2005 | CN1183111C Cycloalkano-indole and cycloalkane-azaindole derivatives, process for their preparation and pharmaceutical commposition containing the same |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/05/2005 | CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 01/05/2005 | CN1182865C Medicine for treating discomforts in insteines and stomach |
| 01/05/2005 | CN1182860C Medicines for treating hepatitis B and preparation thereof |
| 01/05/2005 | CN1182844C Use of dialkylfumarates |
| 01/05/2005 | CN1182843C Use of trans-diphenylethene derivs in preventing or treating liver fibrosis |
| 01/05/2005 | CN1182841C New pharmaceutical formulation and preparation process |
| 01/05/2005 | CN1182831C Synergistic antibacterial combination |
| 01/04/2005 | US6838584 Estrogen receptor modulators |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838558 Useful in the treatment and control of solid tumors |
| 01/04/2005 | US6838476 Imidazoles with anti-inflammatory activity |
| 01/04/2005 | US6838468 4-(phenyl-piperdin-4-ylidene methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/04/2005 | US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 01/04/2005 | US6838456 Condensed pyridoindole derivatives |
| 01/04/2005 | US6838454 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/04/2005 | US6838442 Administering to said subject a jointly effective amount of a glucose reabsorption inhibitor; administering jointly effective amount of an retinoid-X receptor modulator for therapy of diabetes or Syndrome X |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | CA2301503C Pharmaceutical compositions for oral administration of molecular iodine |
| 12/30/2004 | US20040267025 Compounds for the treatment of metabolic disorders |
| 12/30/2004 | US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 12/30/2004 | US20040267010 For therapy of central nervous system disorders |
| 12/30/2004 | US20040266989 Methods and compositions for the treatment of gastrointestinal disorders |
| 12/30/2004 | US20040266876 Method for preventing and treating visceral pain and gastrointestinal disorders |
| 12/30/2004 | US20040266870 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
| 12/30/2004 | US20040266861 Administering a therapeutically effective amount of a compound which is a cannabinoid receptor agonist, a pharmaceutically acceptable salt of the compound, an isomer of the compound, or a pharmaceutically acceptable salt of the isomer |
| 12/30/2004 | US20040266842 Thiazolyl substituted triazoles as alk5 inhibitors |
| 12/30/2004 | US20040266841 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 12/30/2004 | US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266826 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 12/30/2004 | US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis |
| 12/30/2004 | US20040266822 Secondary amines; tissue specificity; reduced side effects; cardiovascular diseases, diabetes, bronchial and urinary smooth muscle spasms, ischemia, anoxic nerve injury |
| 12/30/2004 | US20040266816 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders |
| 12/30/2004 | US20040266801 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd) |
| 12/30/2004 | US20040266799 Corticotropin-releasing factor (CRF); such as 4-chloro-2-methyl-5-nitro-8-(2,4-dichloro)phenyl-1,7-naphthyridine for treating stroke, anxiety, depression, and/or irritable bowel syndrome |
| 12/30/2004 | US20040266792 Hydroxyrisperidone compositions and methods |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/30/2004 | US20040266775 for human, veterinary, or phytoprotective use, e.g., inhibiting the cellular sodium-proton antiporter activity, for the treatment of cardiovascular diseases, metabolic diseases, cancerous diseases or fibrotic diseases |
| 12/30/2004 | US20040266773 Such as 4-(3-methoxyphenyl)-5-methyl-6-(2-fluorobenzyl)-2-(N-(2-pyridyl)ethyl-N -methyl)ethyl-pyridazin-3-one; drugs/prodrugs for treatment of sex-hormone related conditions in men/women |
| 12/30/2004 | US20040266770 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
| 12/30/2004 | US20040266765 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 12/30/2004 | US20040266764 Hydroxamic acid derivatives |
| 12/30/2004 | US20040266750 Beta-lactamyl vasopressin v1aantagonists |
| 12/30/2004 | US20040266722 4'-Substituted nucleoside derivatives as inhibitors of HCV RNA replication |
| 12/30/2004 | US20040266692 Gastrointestinal disorders |
| 12/30/2004 | US20040266687 Antiproliferative agents; antiinflammatory agents; angiogenesis inhibitors; anticancer agents |
| 12/30/2004 | US20040265971 Cytokine for use in stem cell propagation and treatment ot cardiovascular, bone, nervous system and inflammatory disorders |
| 12/30/2004 | US20040265968 Tissue plasminogen activator-like protease |
| 12/30/2004 | US20040265890 a polypeptide of given amino acid sequence; use as drug target for gastrointestinal disorders; fusion proteins; diagnosis |
| 12/30/2004 | US20040265466 Oil composition |
| 12/30/2004 | US20040265427 Novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate |
| 12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 12/30/2004 | US20040265370 Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
| 12/30/2004 | US20040265357 Combination of liponic acid and glutamine in food and pharmaceutical products |
| 12/30/2004 | US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative |
| 12/30/2004 | US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target |
| 12/30/2004 | US20040261190 Hydrazono-malonitriles |
| 12/30/2004 | DE20318975U1 Pharmaceutical composition for treating dental or gum diseases contains vervain and/or rib-wort or materials containing them or their extracts |
| 12/29/2004 | WO2004113344A1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 12/29/2004 | WO2004113340A1 Novel imidazopyridine compound iii with therapeutic effect |
| 12/29/2004 | WO2004113339A1 Novel imidazopyridine compound ii with therapeutic effect |
| 12/29/2004 | WO2004113338A1 Novel imidazopyridine compound i with therapeutic effect |
| 12/29/2004 | WO2004113319A1 Novel chromene compound |